FDA Grants Accelerated Approval to Sunvozertinib for Metastatic Non-Small Cell Lung Cancer with EGFR exon 20 Insertion Mutations By Ogkologos - July 25, 2025 226 0 Facebook Twitter Google+ Pinterest WhatsApp FDA also approved the Oncomine Dx Express Test as a companion diagnostic device Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Poherdy Whole-Genome Sequencing Meets Diagnostic Requirements in Routine Practice for Patients with Solid Cancers FDA Approves Relacorilant with nab-Paclitaxel for Platinum-Resistant Epithelial Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer MOST POPULAR Does Eating Processed Meat Increase Your Risk for Cancer? September 19, 2023 After Saving Thousands of Dogs, Tragedy Strikes Famed Rescue Family January 4, 2022 Immunotherapy before Surgery Appears Effective for Some with Melanoma October 12, 2022 Studying Molecular Subtypes of Peritoneal Metastases in Gastric Cancer September 6, 2021 Load more HOT NEWS FDA Approves Tafasitamab-cxix for Relapsed or Refractory Follicular Lymphoma Glucose Control Key in Reducing Cancer Risk for People with Type... Adding More Mushrooms to Your Diet May Decrease Your Risk of... Black Women Have Nearly Three Times the Risk of Developing Triple...
